5 Item 1A. Risk Factors 20 Item 1B. Unresolved Staff Comments 49 Item 1C Cybersecurity 49 Item 2. Properties 50 Item 3. Legal Proceedings 51 Item 4. Mine Safety Disclosures 51 PART II 52 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 52 Item 6. [Reserved] 52 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 53 Item 7A. Quantitative and Qualitative Disclosure About Market Risks 67 Item ...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-108346 | EDGAR | 80K words |
| 2025-03-17 | 2024-12-31 | 0000950170-25-040280 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0000950170-24-020161 | EDGAR | — |
| 2023-02-27 | 2022-12-31 | 0000950170-23-004668 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001564590-22-007632 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001564590-21-009871 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001564590-20-008161 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001564590-19-004979 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003508 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001564590-17-003095 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-274241 | EDGAR | 53K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106549 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069203 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125388 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091808 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053554 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059394 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039070 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018814 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022605 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0000950170-22-015530 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0000950170-22-008573 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001193125-26-108324 | EDGAR | 3K words |
| 2026-01-07 | 0001193125-26-006327 | EDGAR | — |
| 2025-11-10 | 0001193125-25-274192 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269529 | EDGAR | — |
| 2025-09-05 | 0000921299-25-000007 | EDGAR | — |
| 2025-09-02 | 0000950170-25-112341 | EDGAR | — |
| 2025-08-18 | 0000950170-25-109571 | EDGAR | — |
| 2025-08-14 | 0000950170-25-108280 | EDGAR | — |
| 2025-08-11 | 0000950170-25-106534 | EDGAR | — |
| 2025-07-14 | 0000950170-25-095628 | EDGAR | — |
218 total filings indexed. 186 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000921299 |
| Ticker | KYNB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.kyntrabio.com |
| Listed | 2014-11-14 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report